Bio-Rad Laboratories Total Assets 2010-2024 | BIO
- Bio-Rad Laboratories total assets for the quarter ending September 30, 2024 were $10.603B, a 10.86% decline year-over-year.
- Bio-Rad Laboratories total assets for 2023 were $12.299B, a 8.91% decline from 2022.
- Bio-Rad Laboratories total assets for 2022 were $13.502B, a 24.15% decline from 2021.
- Bio-Rad Laboratories total assets for 2021 were $17.799B, a 37.21% increase from 2020.
Bio-Rad Laboratories Annual Total Assets (Millions of US $) |
|
---|---|
2023 | $12,299 |
2022 | $13,502 |
2021 | $17,799 |
2020 | $12,973 |
2019 | $8,009 |
2018 | $5,611 |
2017 | $4,273 |
2016 | $3,851 |
2015 | $3,710 |
2014 | $3,341 |
2013 | $3,389 |
2012 | $3,444 |
2011 | $3,097 |
2010 | $3,063 |
2009 | $2,536 |
Bio-Rad Laboratories Quarterly Total Assets (Millions of US $) |
|
---|---|
2024-09-30 | $10,603 |
2024-06-30 | $9,688 |
2024-03-31 | $12,610 |
2023-12-31 | $12,299 |
2023-09-30 | $11,896 |
2023-06-30 | $11,978 |
2023-03-31 | $13,667 |
2022-12-31 | $13,502 |
2022-09-30 | $12,058 |
2022-06-30 | $12,682 |
2022-03-31 | $14,374 |
2021-12-31 | $17,799 |
2021-09-30 | $19,953 |
2021-06-30 | $15,118 |
2021-03-31 | $13,933 |
2020-12-31 | $12,973 |
2020-09-30 | $12,021 |
2020-06-30 | $10,097 |
2020-03-31 | $8,684 |
2019-12-31 | $8,009 |
2019-09-30 | $7,177 |
2019-06-30 | $7,647 |
2019-03-31 | $6,863 |
2018-12-31 | $5,611 |
2018-09-30 | $6,719 |
2018-06-30 | $6,386 |
2018-03-31 | $6,215 |
2017-12-31 | $4,273 |
2017-09-30 | $4,186 |
2017-06-30 | $4,143 |
2017-03-31 | $3,953 |
2016-12-31 | $3,851 |
2016-09-30 | $4,020 |
2016-06-30 | $3,875 |
2016-03-31 | $3,753 |
2015-12-31 | $3,710 |
2015-09-30 | $3,666 |
2015-06-30 | $3,525 |
2015-03-31 | $3,326 |
2014-12-31 | $3,341 |
2014-09-30 | $3,386 |
2014-06-30 | $3,468 |
2014-03-31 | $3,441 |
2013-12-31 | $3,389 |
2013-09-30 | $3,280 |
2013-06-30 | $3,483 |
2013-03-31 | $3,457 |
2012-12-31 | $3,444 |
2012-09-30 | $3,303 |
2012-06-30 | $3,169 |
2012-03-31 | $3,188 |
2011-12-31 | $3,097 |
2011-09-30 | $2,970 |
2011-06-30 | $3,044 |
2011-03-31 | $2,909 |
2010-12-31 | $3,063 |
2010-09-30 | $2,682 |
2010-06-30 | $2,527 |
2010-03-31 | $2,547 |
2009-12-31 | $2,536 |
2009-09-30 | $2,478 |
2009-06-30 | $2,344 |
2009-03-31 | $1,955 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $9.670B | $2.671B |
Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $222.392B | 27.46 |
Boston Scientific (BSX) | United States | $154.781B | 41.84 |
Stryker (SYK) | United States | $150.988B | 32.49 |
EssilorLuxottica (ESLOY) | France | $128.761B | 0.00 |
Medtronic (MDT) | Ireland | $116.457B | 17.30 |
Lonza Group Ag (LZAGY) | Switzerland | $48.724B | 0.00 |
Haleon (HLN) | United Kingdom | $43.049B | 27.97 |
Agilent Technologies (A) | United States | $42.120B | 27.91 |
GE HealthCare Technologies (GEHC) | United States | $40.456B | 20.98 |
ResMed (RMD) | United States | $34.834B | 26.83 |
Terumo (TRUMY) | Japan | $27.701B | 39.39 |
Koninklijke Philips (PHG) | Netherlands | $25.801B | 19.75 |
Zimmer Biomet Holdings (ZBH) | United States | $20.443B | 12.84 |
Insulet (PODD) | United States | $20.179B | 80.36 |
Baxter (BAX) | United States | $15.731B | 10.24 |
Smith & Nephew SNATS (SNN) | United Kingdom | $11.039B | 0.00 |
Sunny Optical Technology (SNPTF) | China | $9.976B | 0.00 |
BellRing Brands (BRBR) | United States | $9.951B | 37.15 |
Demant (WILYY) | Denmark | $7.946B | 0.00 |
Lantheus Holdings (LNTH) | United States | $6.320B | 14.69 |
Prestige Consumer Healthcare (PBH) | United States | $4.316B | 20.65 |
ICU Medical (ICUI) | United States | $3.878B | 36.92 |
Envista Holdings (NVST) | United States | $3.750B | 29.85 |
Perrigo (PRGO) | Ireland | $3.407B | 10.03 |
Haemonetics (HAE) | United States | $3.164B | 14.89 |
GN Store Nord (GNNDY) | Denmark | $3.123B | 21.05 |
Shandong Weigao Medical Polymer (SHWGF) | China | $2.989B | 0.00 |
QuidelOrtho (QDEL) | United States | $2.832B | 18.23 |
Neogen (NEOG) | United States | $2.315B | 26.67 |
LeMaitre Vascular (LMAT) | United States | $2.245B | 54.55 |
AtriCure (ATRC) | United States | $1.997B | 0.00 |
Green Thumb Industries (GTBIF) | United States | $1.513B | 26.48 |
AdaptHealth (AHCO) | United States | $1.300B | 9.29 |
InMode (INMD) | Israel | $1.269B | 10.61 |
Maravai LifeSciences Holdings (MRVI) | United States | $1.250B | 0.00 |
BioLife Solutions (BLFS) | United States | $1.215B | 0.00 |
Curaleaf Holdings (CURLF) | Canada | $1.069B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.996B | 15.27 |
Evolus (EOLS) | United States | $0.849B | 0.00 |
CeriBell (CBLL) | United States | $0.810B | 0.00 |
Owens & Minor (OMI) | United States | $0.667B | 5.21 |
Capricor Therapeutics (CAPR) | United States | $0.652B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.627B | 27.14 |
Valneva SE (VALN) | France | $0.563B | 0.00 |
Omeros (OMER) | United States | $0.526B | 0.00 |
SNDL (SNDL) | Canada | $0.507B | 0.00 |
Surmodics (SRDX) | United States | $0.487B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.474B | 0.00 |
Verano Holdings (VRNOF) | United States | $0.424B | 0.00 |
ZimVie (ZIMV) | United States | $0.383B | 32.26 |
Canopy Growth (CGC) | Canada | $0.363B | 0.00 |
Aurora Cannabis (ACB) | Canada | $0.343B | 62.50 |
Cerus (CERS) | United States | $0.323B | 0.00 |
Quanterix (QTRX) | United States | $0.320B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.317B | 30.11 |
Sanara MedTech (SMTI) | United States | $0.309B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.292B | 19.55 |
Biote (BTMD) | United States | $0.261B | 5.73 |
Zynex (ZYXI) | United States | $0.252B | 52.80 |
High Tide (HITI) | Canada | $0.238B | 0.00 |
Sanuwave Health (SNWV) | United States | $0.232B | 3.26 |
SEMPERIT AG HLD (SEIGY) | Austria | $0.226B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.209B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.209B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.203B | 15.16 |
Brainsway (BWAY) | Israel | $0.200B | 106.40 |
MacroGenics (MGNX) | United States | $0.174B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.164B | 0.00 |
FitLife Brands (FTLF) | United States | $0.142B | 17.83 |
Jin Medical (ZJYL) | China | $0.130B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.127B | 0.00 |
Fonar (FONR) | United States | $0.101B | 11.44 |
Exagen (XGN) | United States | $0.093B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
Veru (VERU) | United States | $0.085B | 0.00 |
InterCure (INCR) | Israel | $0.080B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.073B | 0.00 |
INLIF (INLF) | $0.067B | 0.00 | |
Rockwell Medical (RMTI) | United States | $0.064B | 33.00 |
Cytosorbents (CTSO) | United States | $0.057B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.055B | 0.00 |
Apyx Medical (APYX) | United States | $0.052B | 0.00 |
MariMed (MRMD) | United States | $0.051B | 0.00 |
United-Guardian (UG) | United States | $0.051B | 14.60 |
Modular Medical (MODD) | United States | $0.048B | 0.00 |
ImmuCell (ICCC) | United States | $0.048B | 0.00 |
Safety Shot (SHOT) | United States | $0.035B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.017B | 0.00 |
Nephros (NEPH) | United States | $0.016B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
Flora Growth (FLGC) | United States | $0.013B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.012B | 0.00 |
NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
Agape ATP (ATPC) | $0.005B | 0.00 | |
IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
Senestech (SNES) | United States | $0.003B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
Sharps Technology (STSS) | United States | $0.002B | 0.00 |
GlucoTrack (GCTK) | United States | $0.001B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |